General Announcement::Intimation of Board Meeting to consider repurchase of Foreign Currency Debt

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
25-Sep-2018 19:01:19
Status
New
Announcement Sub Title
Intimation of Board Meeting to consider repurchase of Foreign Currency Debt
Announcement Reference
SG180925OTHR9B23
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary Compliance Officer
Effective Date and Time of the event
25/09/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
Intimation of Board Meeting to consider repurchase of Foreign Currency Debt

Attachments

Stock_Exchange_Letters_BBM.pdf
Total size =3169K